How to Source Ipilimumab for Pharmaceutical Formulation
Ipilimumab (Injection, 5 mg/1 mL (vial)) is classified under Oncology Cancer Care. It is therapeutically aligned with reference brands such as Yervoy® (EU & US). This guide highlights key sourcing factors buyers should consider when procuring high-quality Ipilimumab for formulation, R&D, or bulk manufacturing.
Product Overview:
pilimumab (brand name Yervoy®) is a monoclonal antibody used in oncology to treat cancers like melanoma, renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC). It works by blocking the CTLA-4 receptor on T-cells, which enhances the immune system’s ability to attack cancer cells. It is available in intravenous (IV) form with a strength of 5 mg/1 mL.
Ipilimumab (brand name Yervoy®) is a monoclonal antibody used in oncology as an immune checkpoint in...
Ipilimumab API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Ipilimumab must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Ipilimumab is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Ipilimumab is more than procurement—it’s a strategic partnership. With its injection form and 5 mg/1 mL (vial) specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Frequently Asked Questions For Sourcing of Ipilimumab
What is the typical lead time for Ipilimumab?
Lead times range from 4–6 weeks depending on supplier and region.
Is Ipilimumab available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Ipilimumab require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Ipilimumab?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Ipilimumab?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Ipilimumab?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Ipilimumab suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Ipilimumab be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Subscribe to Our Newsletter
Stay updated on pharma trends and marketplace opportunities.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.